Editorial: Model-informed decision making in the preclinical stages of pharmaceutical research and development.
作者信息
Li Rui, Craig Morgan, D'Argenio David Z, Betts Alison, Mager Donald E, Maurer Tristan S
机构信息
Translational Modeling and Simulation, Medicine Design, Pfizer Inc., Cambridge, MA, United States.
Department of Mathematics and Statistics, Université de Montréal, Montréal, QC, Canada.
出版信息
Front Pharmacol. 2023 Apr 12;14:1184914. doi: 10.3389/fphar.2023.1184914. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Model-informed decision making in the preclinical stages of pharmaceutical research and development.社论：药物研发临床前阶段的模型驱动决策
Front Pharmacol. 2023 Apr 12;14:1184914. doi: 10.3389/fphar.2023.1184914. eCollection 2023.
2
Navigating Between Right, Wrong, and Relevant: The Use of Mathematical Modeling in Preclinical Decision Making.在正确、错误与相关之间导航：数学建模在临床前决策中的应用
Front Pharmacol. 2022 Apr 12;13:860881. doi: 10.3389/fphar.2022.860881. eCollection 2022.
3
Alternative strategies in drug development: clinical pharmacological aspects.药物研发中的替代策略：临床药理学方面。
Int J Clin Pharmacol Ther. 1999 Dec;37(12):575-83.
4
Use of Simulation Modeling to Inform Decision Making for Health Care Systems and Policy in Colorectal Cancer Screening: Protocol for a Systematic Review.利用模拟建模为结直肠癌筛查中的医疗保健系统和政策决策提供信息：一项系统评价方案
JMIR Res Protoc. 2020 May 13;9(5):e16103. doi: 10.2196/16103.
5
Preclinical pharmacokinetic/pharmacodynamic modeling and simulation in the pharmaceutical industry: an IQ consortium survey examining the current landscape.制药行业的临床前药代动力学/药效学建模与模拟：IQ联盟对当前现状的调查
AAPS J. 2015 Mar;17(2):462-73. doi: 10.1208/s12248-014-9716-2. Epub 2015 Jan 29.
6
[Clinical-pharmacological aspects to accelerate the development process from the preclinical to the clinical phase/1st communication: The contribution of clinical pharmacology].[加速从临床前到临床阶段开发进程的临床药理学方面/首次交流：临床药理学的贡献]
Arzneimittelforschung. 2004;54(5):251-8. doi: 10.1055/s-0031-1296967.
7
A Model-Informed Drug Discovery and Development Strategy for the Novel Glucose-Responsive Insulin MK-2640 Enabled Rapid Decision Making.一种基于模型的药物发现和开发策略，用于新型葡萄糖响应胰岛素 MK-2640，可实现快速决策。
Clin Pharmacol Ther. 2020 Jun;107(6):1296-1311. doi: 10.1002/cpt.1729. Epub 2020 Feb 3.
8
Application of Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Antibody-Drug Conjugate Development.药代动力学-药效学建模与模拟在抗体药物偶联物研发中的应用。
Pharm Res. 2015 Nov;32(11):3508-25. doi: 10.1007/s11095-015-1626-1. Epub 2015 Feb 11.
9
Pharmacokinetics/Pharmacodynamics and the stages of drug development: role of modeling and simulation.药代动力学/药效学与药物研发阶段：建模与模拟的作用
AAPS J. 2005 Oct 7;7(3):E544-59. doi: 10.1208/aapsj070355.
10
Effective visualization of integrated knowledge and data to enable informed decisions in drug development and translational medicine.有效可视化整合的知识和数据，以支持药物研发和转化医学中的决策。
J Transl Med. 2013 Oct 8;11:250. doi: 10.1186/1479-5876-11-250.
本文引用的文献
1
A Mechanistic Site-Of-Action Model: A Tool for Informing Right Target, Right Compound, And Right Dose for Therapeutic Antagonistic Antibody Programs.一种作用机制位点模型：一种用于为治疗性拮抗抗体项目确定正确靶点、正确化合物和正确剂量提供信息的工具。
Front Bioinform. 2021 Sep 3;1:731340. doi: 10.3389/fbinf.2021.731340. eCollection 2021.
2
Predicting the Effects of Drug Combinations Using Probabilistic Matrix Factorization.使用概率矩阵分解预测药物组合的效果。
Front Bioinform. 2021 Aug 13;1:708815. doi: 10.3389/fbinf.2021.708815. eCollection 2021.
3
PBPK-PD modeling for the preclinical development and clinical translation of tau antibodies for Alzheimer's disease.用于阿尔茨海默病tau抗体临床前开发和临床转化的生理药代动力学-药效学（PBPK-PD）建模
Front Pharmacol. 2022 Sep 2;13:867457. doi: 10.3389/fphar.2022.867457. eCollection 2022.
4
Early Feasibility Assessment: A Method for Accurately Predicting Biotherapeutic Dosing to Inform Early Drug Discovery Decisions.早期可行性评估：一种准确预测生物治疗剂量以指导早期药物发现决策的方法。
Front Pharmacol. 2022 Jun 8;13:864768. doi: 10.3389/fphar.2022.864768. eCollection 2022.
5
An Model of T Cell Infiltration Dynamics Based on an Advanced System to Enhance Preclinical Decision Making in Cancer Immunotherapy.基于先进系统的T细胞浸润动力学模型，以增强癌症免疫治疗中的临床前决策。
Front Pharmacol. 2022 May 2;13:837261. doi: 10.3389/fphar.2022.837261. eCollection 2022.
6
Minimal Physiologically-Based Pharmacokinetic (mPBPK) Metamodeling of Target Engagement in Skin Informs Anti-IL17A Drug Development in Psoriasis.基于最小生理药代动力学（mPBPK）的皮肤靶点参与元建模为银屑病抗IL17A药物开发提供信息。
Front Pharmacol. 2022 Apr 25;13:862291. doi: 10.3389/fphar.2022.862291. eCollection 2022.
7
Mathematical Modeling of Complement Pathway Dynamics for Target Validation and Selection of Drug Modalities for Complement Therapies.用于补体疗法靶点验证和药物模式选择的补体途径动力学数学建模
Front Pharmacol. 2022 Apr 19;13:855743. doi: 10.3389/fphar.2022.855743. eCollection 2022.
8
Navigating Between Right, Wrong, and Relevant: The Use of Mathematical Modeling in Preclinical Decision Making.在正确、错误与相关之间导航：数学建模在临床前决策中的应用
Front Pharmacol. 2022 Apr 12;13:860881. doi: 10.3389/fphar.2022.860881. eCollection 2022.
9
Predictive Simulations in Preclinical Oncology to Guide the Translation of Biologics.临床前肿瘤学中的预测性模拟以指导生物制剂的转化
Front Pharmacol. 2022 Mar 3;13:836925. doi: 10.3389/fphar.2022.836925. eCollection 2022.
10
Physiological Considerations for Modeling Antibody-Target Interactions.抗体-靶点相互作用建模的生理学考量
Front Pharmacol. 2022 Feb 24;13:856961. doi: 10.3389/fphar.2022.856961. eCollection 2022.
Zotero 插件